share_log

Insider Spends CN¥134m Buying More Shares In Rici Healthcare Holdings

Insider Spends CN¥134m Buying More Shares In Rici Healthcare Holdings

內幕人士花費1.34億元人民幣購買瑞慈醫療控股的更多股票
Simply Wall St ·  2023/12/24 19:44

Rici Healthcare Holdings Limited (HKG:1526) shareholders (or potential shareholders) will be happy to see that the VP & Executive Director, Hong Mei, recently bought a whopping HK$134m worth of stock, at a price of HK$0.50. Aside from being a solid chunk in its own right, the deft move also saw their holding increase by some 31%.

瑞智醫療控股有限公司(HKG: 1526)的股東(或潛在股東)將很高興看到副總裁兼執行董事洪梅最近以0.50港元的價格購買了價值高達1.34億港元的股票。這一靈巧的舉動不僅本身就佔據了相當大的份額,還使他們的持股量增加了約31%。

See our latest analysis for Rici Healthcare Holdings

查看我們對瑞慈醫療控股公司的最新分析

Rici Healthcare Holdings Insider Transactions Over The Last Year

瑞慈醫療控股去年內幕交易

Notably, that recent purchase by Hong Mei is the biggest insider purchase of Rici Healthcare Holdings shares that we've seen in the last year. Even though the purchase was made at a significantly lower price than the recent price (HK$1.12), we still think insider buying is a positive. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

值得注意的是,洪美最近的收購是我們去年對Rici Healthcare Holdings股票的最大一次內幕收購。儘管此次收購的價格明顯低於近期價格(1.12港元),但我們仍然認爲內幕買入是積極的。由於它是以較低的估值發生的,因此它並不能告訴我們內部人士是否會認爲今天的價格具有吸引力。

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

你可以在下面看到過去 12 個月內幕交易(公司和個人)的直觀描述。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

insider-trading-volume
SEHK:1526 Insider Trading Volume December 25th 2023
SEHK: 1526 內幕交易量 2023 年 12 月 25 日

There are always plenty of stocks that insiders are buying. So if that suits your style you could check each stock one by one or you could take a look at this free list of companies. (Hint: insiders have been buying them).

內部人士總是會買入很多股票。因此,如果這適合你的風格,你可以逐一查看每隻股票,也可以看看這份免費的公司名單。(提示:業內人士一直在購買它們)。

Does Rici Healthcare Holdings Boast High Insider Ownership?

Rici Healthcare Holdings是否擁有很高的內部所有權?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Rici Healthcare Holdings insiders own about HK$977m worth of shares (which is 55% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

測試公司領導者與其他股東之間一致性的另一種方法是查看他們擁有多少股份。通常,內部人士的所有權越高,內部人士長期建立公司的可能性就越大。瑞慈醫療控股內部人士擁有價值約9.77億港元的股份(佔該公司55%的股份)。我喜歡看到這種程度的內部所有權,因爲它增加了管理層考慮股東最大利益的機會。

So What Do The Rici Healthcare Holdings Insider Transactions Indicate?

那麼,瑞慈醫療控股公司的內幕交易表明了什麼?

It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Rici Healthcare Holdings. Looks promising! I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow for free.

很高興看到最近的內幕收購。長期的內幕交易也給了我們信心。除了較高的內部所有權外,該分析還表明,內部人士對Rici Healthcare Holdings非常看好。看起來很有希望!我喜歡更深入地了解一家公司過去的表現。您可以免費訪問這張過去的收入、收入和現金流的交互式圖表。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是那些向相關監管機構報告交易的個人。目前,我們僅對公開市場交易和直接利益的私人處置進行覈算,但不考慮衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論